{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:19Z","timestamp":1791999919208,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHS114027"],"award-info":[{"award-number":["EDAHS114027"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHS113046"],"award-info":[{"award-number":["EDAHS113046"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHS115032"],"award-info":[{"award-number":["EDAHS115032"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 111-2320-B-214-002-MY3"],"award-info":[{"award-number":["MOST 111-2320-B-214-002-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2320-B-214-002"],"award-info":[{"award-number":["NSTC 114-2320-B-214-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031258","name":"UCSI University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Government of Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/WAB13\/UCSI\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Government of Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/SKK06\/UCSI\/02\/4"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK06\/UCSI\/02\/4"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pbb.2026.174273","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:12:57Z","timestamp":1790377977000},"page":"174273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation"],"prefix":"10.1016","volume":"269","author":[{"given":"Tien-Wei","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Huei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kuo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ning","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2026.174273_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112455","article-title":"Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: emerging approach for new application","volume":"145","author":"Abdelhamid","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbb.2026.174273_bb0010","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","article-title":"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pbb.2026.174273_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"Ahles","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pbb.2026.174273_bb0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/13872877251329474","article-title":"Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Abeta(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer\u2019s disease","volume":"105","author":"Alami","year":"2025","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.pbb.2026.174273_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177525","article-title":"The potential neuroprotective effect of empagliflozin against depressive-like behavior induced by chronic unpredictable mild stress in rats: involvement of NLRP3 inflammasome","volume":"998","author":"Ali","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123659","article-title":"The ameliorative effect of empagliflozin in vigabatrin-induced cerebellar\/neurobehavioral deficits: targeting mTOR\/AMPK\/SIRT-1 signaling pathways","volume":"27","author":"Amer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pbb.2026.174273_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108861","article-title":"Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure","volume":"270","author":"Armillotta","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2026.174273_bb0040","first-page":"120","article-title":"The association between diabetes mellitus and depression","volume":"9","author":"Badescu","year":"2016","journal-title":"J. Med. Life"},{"key":"10.1016\/j.pbb.2026.174273_bb0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.pbb.2026.174273_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112233","article-title":"Chemobrain in rats: behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration","volume":"378","author":"Cardoso","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2026.174273_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.019","article-title":"Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma","volume":"367","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pbb.2026.174273_bb0060","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.2009.27.2757","article-title":"Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Choueiri","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pbb.2026.174273_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2026.174273_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114448","article-title":"Dapagliflozin inhibits the activity of lateral habenula to alleviate diabetes mellitus-induced depressive-like behavior","volume":"366","author":"Dong","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2026.174273_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pbb.2026.174273_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-019-03827-0","article-title":"Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain","volume":"84","author":"El-Agamy","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.pbb.2026.174273_bb0090","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202403417RR","article-title":"Astrocytic FABP7 alleviates depression-like behaviors of chronic unpredictable mild stress mice by regulating neuroinflammation and hippocampal spinogenesis","volume":"39","author":"Geng","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.pbb.2026.174273_bb0095","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41591-020-1014-1","article-title":"Treating cancer therapy-related cognitive impairment","volume":"26","author":"Gibson","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2026.174273_bb0100","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.2174\/1381612824666181120094749","article-title":"Synaptic plasticity in PTSD and associated comorbidities: the function and mechanism for diagnostics and therapy","volume":"24","author":"He","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2026.174273_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.psyneuen.2018.12.233","article-title":"Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder","volume":"102","author":"Innes","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2026.174273_bb0110","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s13300-023-01481-7","article-title":"The effects of sodium-glucose cotransporter 2 inhibitors on body composition in type 2 diabetes mellitus: a narrative review","volume":"14","author":"Jahangiri","year":"2023","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pbb.2026.174273_bb0115","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00213-021-05977-7","article-title":"Animal models of chemotherapy-induced cognitive decline in preclinical drug development","volume":"238","author":"John","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174273_bb0120","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1007\/s00213-022-06250-1","article-title":"Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray","volume":"239","author":"Kan","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174273_bb0125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13318-020-00639-z","article-title":"The influence of paracetamol on the penetration of Sorafenib and Sorafenib N-oxide through the blood-brain barrier in rats","volume":"45","author":"Karbownik","year":"2020","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.pbb.2026.174273_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110431","article-title":"Chronic stress-related behavioral and synaptic changes require caspase-3 activation in the ventral hippocampus of male mice","volume":"272","author":"Kwon","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174273_bb0135","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","article-title":"Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors","volume":"30","author":"Lange","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.pbb.2026.174273_bb0140","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1007\/s12035-023-03439-z","article-title":"Impaired ventrolateral periaqueductal gray-ventral tegmental area pathway contributes to chronic pain-induced depression-like behavior in mice","volume":"60","author":"Lee","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2026.174273_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20075371","article-title":"Effects of voluntary wheel running exercise on chemotherapy-impaired cognitive and motor performance in mice","volume":"20","author":"Lee","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pbb.2026.174273_bb0150","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/02698811251351611","article-title":"Boosting the ventrolateral periaqueductal gray-ventral tegmental area pathway by disinhibition of group II mGluRs alleviates chronic restraint stress-induced depression-like behavior in mice","volume":"39","author":"Lee","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106598","article-title":"Sotagliflozin attenuates cardiac dysfunction and depression-like behaviors in mice with myocardial infarction through the gut-heart-brain axis","volume":"199","author":"Liao","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2026.174273_bb0160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HRP.0000000000000374","article-title":"Sodium-glucose cotransporter-2 inhibitors in depression","volume":"31","author":"Liebers","year":"2023","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174273_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pbb.2009.09.001","article-title":"Systemic administration of doxorubicin impairs aversively motivated memory in rats","volume":"94","author":"Liedke","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2026.174273_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","article-title":"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.pbb.2026.174273_bb0175","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbb.2026.174273_bb0180","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1002\/tox.24362","article-title":"Sodium-glucose co-transporter-2 inhibitor Empagliflozin attenuates Sorafenib-induced myocardial inflammation and toxicity","volume":"39","author":"Liu","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.pbb.2026.174273_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2026.174273_bb0190","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopsych.2009.10.018","article-title":"The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents","volume":"67","author":"Malkesman","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174273_bb0195","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00213-024-06663-0","article-title":"Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy\/inflammation and PKCzeta-mediated neurogenesis","volume":"241","author":"Muhammad","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174273_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2407-14-219","article-title":"Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study","volume":"14","author":"Mulder","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pbb.2026.174273_bb0205","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/neuonc\/nor145","article-title":"Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma","volume":"13","author":"Nabors","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.pbb.2026.174273_bb0210","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/db10-1371","article-title":"Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain","volume":"60","author":"Navaratna","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.pbb.2026.174273_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178961","article-title":"Heart-brain axis dysregulation in PTSD mice: vagal-mediated insular cortex hyperactivity and its reversal by propranolol","volume":"1025","author":"Niu","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainresbull.2021.04.017","article-title":"Chronic unpredictable stress negatively regulates hippocampal neurogenesis and promote anxious depression-like behavior via upregulating apoptosis and inflammatory signals in adult rats","volume":"172","author":"Parul","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2026.174273_bb0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hipo.1116","article-title":"Effects of chronic stress on hippocampal long-term potentiation","volume":"12","author":"Pavlides","year":"2002","journal-title":"Hippocampus"},{"key":"10.1016\/j.pbb.2026.174273_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pbb.2026.174273_bb0235","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2026.174273_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14100999","article-title":"Effects of cannabidiol (CBD) on doxorubicin-induced anxiety and depression-like behaviors and mRNA expression of inflammatory markers in rats","volume":"14","author":"Poudel","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.pbb.2026.174273_bb0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-023-02744-7","article-title":"Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption","volume":"20","author":"Qin","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2026.174273_bb0250","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biopsych.2018.08.021","article-title":"The hippocampus in depression: more than the sum of its parts? Advanced hippocampal substructure segmentation in depression","volume":"85","author":"Roddy","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174273_bb0255","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2026.174273_bb0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbr.2009.02.025","article-title":"Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats","volume":"201","author":"Seigers","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2026.174273_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312697","article-title":"Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: a review of physiological mechanisms and interventions","volume":"22","author":"Sekeres","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2026.174273_bb0270","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: pathogenesis, implications and treatment (review)","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pbb.2026.174273_bb0275","first-page":"1519","article-title":"Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option","volume":"34","author":"Smolle","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pbb.2026.174273_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110651","article-title":"Metformin alleviates memory and hippocampal neurogenesis decline induced by methotrexate chemotherapy in a rat model","volume":"131","author":"Sritawan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbb.2026.174273_bb0285","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1038\/ncomms9543","article-title":"Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward","volume":"6","author":"Stouffer","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbb.2026.174273_bb0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jphs.2016.02.003","article-title":"Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects","volume":"130","author":"Tahara","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2026.174273_bb0295","article-title":"Baicalin alleviates chronic restraint stress-induced depression-like behavior by suppressing ROS\/H2O2 generation via a BDNF-associated mechanism in mice","volume":"15","author":"Teng","year":"2026","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pbb.2026.174273_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117512","article-title":"Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2\/prostaglandin E(2) axis","volume":"504","author":"Tsai","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnetp.2023.1125495","article-title":"Depression as a cardiovascular disorder: central-autonomic network, brain-heart axis, and vagal perspectives of low mood","volume":"3","author":"Valenza","year":"2023","journal-title":"Front. Netw. Physiol."},{"key":"10.1016\/j.pbb.2026.174273_bb0310","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2215-0366(14)70313-X","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data","volume":"1","author":"Walker","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pbb.2026.174273_bb0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","article-title":"Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2026.174273_bb0320","first-page":"123","article-title":"Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults","volume":"65","author":"Wefel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pbb.2026.174273_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114083","article-title":"Neuroprotective effects of hesperidin against methotrexate-induced changes in neurogenesis and oxidative stress in the adult rat","volume":"178","author":"Welbat","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174273_bb0330","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41419-024-07132-4","article-title":"Regular exercise ameliorates high-fat diet-induced depressive-like behaviors by activating hippocampal neuronal autophagy and enhancing synaptic plasticity","volume":"15","author":"Wu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pbb.2026.174273_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8861903","article-title":"Changes in hippocampal plasticity in depression and therapeutic approaches influencing these changes","volume":"2020","author":"Xu","year":"2020","journal-title":"Neural Plast."},{"key":"10.1016\/j.pbb.2026.174273_bb0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00406-023-01628-4","article-title":"Brain-heart interaction disruption in major depressive disorder: disturbed rhythm modulation of the cardiac cycle on brain transient theta bursts","volume":"274","author":"Zhou","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726001280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726001280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:17Z","timestamp":1791996797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726001280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":68,"alternative-id":["S0091305726001280"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174273","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of sodium-glucose cotransporter 2 prevents sorafenib-induced depression-like behaviors by preserving hippocampal-dependent long-term potentiation","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174273"}}